Esophageal Cancer: Current Advances and Controversies

Moderator(s)

• 

  Sandra Starnes, MD (she/her/hers)

  Professor of Surgery
  University of Cincinnati Medical Center
  Cincinnati, Ohio, United States
• 

  Inderpal Sarkaria, MD

  Professor & Chief
  UT Southwestern Medical Center
  Dallas, Texas, United States

Presentations:

• 9:45am – 9:53am PT

  Endoscopic Therapy for Early-Stage Esophageal Cancer
  

  Invited Speaker: Robert Van Haren, MD, MSPH (he/him/his) – University of Cincinnati
• 9:53am – 9:59am PT

  Optimal Treatment for Esophageal Adenocarcinoma: CROSS
  

  Invited Speaker: Monisha Sudarshan, MD MPH – Cleveland Clinic
• 9:59am – 10:05am PT

  Optimal Treatment for Esophageal Adenocarcinoma: FLOT
  

  Invited Speaker: Jonathan Cools-Lartigue, MD PhD – McGill university
• 10:05am – 10:13am PT

  Discussion
• 10:13am – 10:21am PT

  Surveillance Versus Resection Following Induction Therapy for Esophageal Cancer
  

  Invited Speaker: Biniam Kidane, MD MSc FRCSC (he/him/his) – University of Manitoba
• 10:21am – 10:29am PT

  Emerging Biomarkers in Esophageal Cancer (MSI/MMR, HER2, PDL) and Implications For Treatment
  

  Invited Speaker: Daniela Molena, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
• 10:29am – 10:41am PT

  Panel Discussion
• 10:41am – 10:49am PT

  Esophagectomy vs. Gastrectomy for Gastroesophageal Junction Tumors
  

  Invited Speaker: Stephanie G. Worrell, MD – University of Arizona
• 10:49am – 10:57am PT

  Open Esophagectomy: Tips and Techniques
  

  Invited Speaker: Richard J. Battafarano, MD PhD – Johns Hopkins University School of Medicine and Health System
• 10:57am – 11:05am PT

  RAMIE Tips and Tricks: Is RAMIE the Preferred Approach? Update on Trials
  

  Invited Speaker: Lana Schumacher, MD, MS, FACS (she/her/hers) – Tufts Medical Center
• 11:05am – 11:17am PT

  Panel Discussion
• 11:17am – 11:25am PT

  Post-Esophagectomy Diet Management: Early Esophagram and Diet Advancement
  

  Invited Speaker: Luis F. Tapias, MD – Mayo Clinic
• 11:25am – 11:35am PT

  Association of Adjuvant Immunotherapy with Improved Survival for Stage II-III Esophageal Cancer: Three-Year National Perspective
  

  Presenting Author: Sara Sakowitz, MS MPH (she/her/hers) – UCLA David Geffen School of Medicine